Literature DB >> 3919989

Theophylline kinetics in chronic obstructive airway disease in the elderly.

W Y Au, A K Dutt, N DeSoyza.   

Abstract

Theophylline kinetic studies, serial spirometric function tests, and arterial blood gas determinations were performed in 39 adult men with stable chronic obstructive airway disease (COPD). Subjects were given an intravenous aminophylline loading dose of 5.6 mg/kg and a maintenance dose of 0.9 mg/kg/hr for 6 hours. Elderly (greater than 60 years old) nonsmoking subjects had 36% lower theophylline clearance (Cl) and a 40% longer serum theophylline elimination t1/2 than did middle-aged (less than 60 years old) nonsmoking subjects (mean +/- SE; clearances of 32.6 +/- 3.2 [n = 13] and 50.7 +/- 8.5 ml/kg/hr [n = 8] and t1/2s of 11.0 +/- 0.8 and 7.4 +/- 0.8 hours, respectively). There were also differences in Cl and t1/2 between elderly and middle-aged subjects in both the smoking and nonsmoking groups: elderly group, Cl = 43.6 +/- 3.7 mg/kg/hr and t1/2 = 9.0 +/- 0.7 hours; middle-aged group, Cl = 57.6 +/- 6.0 mg/kg/hr and t1/2 = 6.7 +/- 0.6 hours). There was consistent improvement in spirometric functions in both nonsmoking and smoking elderly subjects: percent changes in forced expiratory volume in 1 second of 19% to 25%; in forced vital capacity of 25% to 31%; in forced expiratory flow at 25% to 75% of vital capacity of 59% to 67%; and in maximum mid-flow time of -25% to -30%, at serum theophylline concentrations of 10 to 13 mg/L (group mean). We conclude that elderly nonsmoking subjects with COPD cleared theophylline more slowly than did middle-aged, nonsmoking subjects with COPD.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3919989     DOI: 10.1038/clpt.1985.74

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  14 in total

Review 1.  Hepatic drug metabolism and aging.

Authors:  C Durnas; C M Loi; B J Cusack
Journal:  Clin Pharmacokinet       Date:  1990-11       Impact factor: 6.447

2.  Bronchodilator treatment for partially reversible chronic obstructive airways disease.

Authors:  M K Tandon; S G Kailis
Journal:  Thorax       Date:  1991-04       Impact factor: 9.139

3.  [Pharmacokinetics and pharmacodynamics of theophylline in geriatric patients with multiple diseases].

Authors:  W Mühlberg; D Platt; M Bauer; U Salzner
Journal:  Klin Wochenschr       Date:  1987-07-15

4.  The relationship between theophylline clearance and age in adult life.

Authors:  S H Jackson; A Johnston; R Woollard; P Turner
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953

5.  The effect of age on theophylline clearance in normal subjects.

Authors:  W C Randolph; J J Seaman; B Dickson; K E Peace; W O Frank; M D Young
Journal:  Br J Clin Pharmacol       Date:  1986-11       Impact factor: 4.335

6.  Effects of time of dosing and age on intravenous aminophylline pharmacokinetics.

Authors:  A Rodgers; K W Woodhouse; D N Bateman
Journal:  Br J Clin Pharmacol       Date:  1987-03       Impact factor: 4.335

Review 7.  Influence of endogenous and exogenous effectors on the pharmacokinetics of theophylline. Focus on biotransformation.

Authors:  U Tröger; F P Meyer
Journal:  Clin Pharmacokinet       Date:  1995-04       Impact factor: 6.447

Review 8.  The pharmacological approach to the elderly COPD patient.

Authors:  Timothy E Albertson; Michael Schivo; Amir A Zeki; Samuel Louie; Mark E Sutter; Mark Avdalovic; Andrew L Chan
Journal:  Drugs Aging       Date:  2013-07       Impact factor: 3.923

Review 9.  The effect of respiratory disorders on clinical pharmacokinetic variables.

Authors:  A M Taburet; C Tollier; C Richard
Journal:  Clin Pharmacokinet       Date:  1990-12       Impact factor: 6.447

10.  What really declines with age? The Hayflick Lecture for 2006 35th American Aging Association.

Authors:  Kenichi Kitani
Journal:  Age (Dordr)       Date:  2007-01-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.